ChronVac- C (NS3/4A DNA vaccine) / Transgene, ChronTech, Inovio  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ChronVac- C (NS3/4A DNA vaccine) / Transgene, Inovio, ChronTech
NCT01335711 / 2010-022960-10: CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Unknown status
2
32
Europe
ChronVac-C + SOC, SOC
ChronTech Pharma AB, Inovio Pharmaceuticals
Chronic Hepatitis C
06/12
06/12
NCT00563173 / 2007-002901-33: Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Unknown status
1/2
12
Europe
CHRONVAC-C®
Tripep AB, Inovio Pharmaceuticals
Chronic Hepatitis C Virus Infection
04/10
04/10

Download Options